6.1 Signs and symptoms of recurrent, residual or metastatic disease
Between 30 and 40 per cent of all patients with sarcomas develop local or distant recurrence (Cancer Council Australia Sarcoma Guidelines Working Party 2014). The risk of recurrence is greatest in the first few years, with approximately two out of three recurrences developing within two years and 95 per cent by five years (of initial diagnosis). Diagnoses can be stratified into risk groups based on the prognostic features of the primary tumour (Cancer Council Australia Sarcoma Guidelines Working Party 2014).